Drug Education on All Medications Provided to Patient/Carer During All Episodes of Care
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Percentage of home health quality episodes of care during which patient/caregiver was instructed on how to monitor the effectiveness of drug therapy, how to recognise potential adverse effects, and how and when to report problems (at the time of or at any time since the most recent SOC/ROC assessment).
Numerator
Number of home health quality episodes of care during which patient/caregiver was instructed on how to monitor the effectiveness of drug therapy, how to recognise potential adverse effects, and how and when to report problems (at the time of or at any time since the most recent SOC/ROC assessment).
Denominator
Number of home health quality episodes of care ending with a discharge or transfer to inpatient facility during the reporting period, other than those covered by generic or measure-specific exclusions.
Exclusions
Home health episodes for which the patient was not taking any drugs since the last OASIS assessment prior to transfer/discharge, or the patient died.
Use of Risk Adjustment
Risk Adjustments
None
Stratifications
None
Data Attributes
Type of Data Collection
Data Collection Methods
Outcome and Assessment Information Set (OASIS). Entry of home health service and the last 5 days of every 60 day period beginning with the start of care date.
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Home Health Quality Reporting (CMS and providers) CMS Care Compare - Home health services and CMS Provider Compare (CMS, providers and publicly reported online).